Haverford Trust CO Abb Vie Inc. Transaction History

Haverford Trust CO

  • $9.55 Billion
  • Q1 2024

A detailed history of Haverford Trust CO transactions in Abb Vie Inc. stock. As of the latest transaction made, Haverford Trust CO holds 98,446 shares of ABBV stock, worth $16.3 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
98,446
Previous 94,943 3.69%
Holding current value
$16.3 Million
Previous $14.7 Million 21.84%
% of portfolio
0.19%
Previous 0.16%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 02, 2024
BUY
$159.82 - $182.1 $559,849 - $637,896
3,503 Added 3.69%
98,446 $17.9 Million
Q4 2023

Feb 08, 2024
BUY
$137.6 - $154.97 $425,596 - $479,322
3,093 Added 3.37%
94,943 $14.7 Million
Q3 2023

Nov 09, 2023
SELL
$133.59 - $154.65 $218,018 - $252,388
-1,632 Reduced 1.75%
91,850 $13.7 Million
Q2 2023

Aug 08, 2023
BUY
$132.51 - $164.9 $81,626 - $101,578
616 Added 0.66%
93,482 $12.6 Million
Q1 2023

May 12, 2023
BUY
$144.61 - $166.54 $224,145 - $258,137
1,550 Added 1.7%
92,866 $14.8 Million
Q4 2022

Feb 13, 2023
BUY
$138.31 - $165.87 $39,833 - $47,770
288 Added 0.32%
91,316 $14.8 Million
Q3 2022

Nov 14, 2022
SELL
$134.21 - $153.93 $711,984 - $816,598
-5,305 Reduced 5.51%
91,028 $12.2 Million
Q2 2022

Aug 12, 2022
SELL
$137.62 - $174.96 $470,660 - $598,363
-3,420 Reduced 3.43%
96,333 $14.8 Million
Q1 2022

May 05, 2022
BUY
$131.98 - $163.75 $17,553 - $21,778
133 Added 0.13%
99,753 $16.2 Million
Q4 2021

Feb 14, 2022
BUY
$107.43 - $135.93 $63,491 - $80,334
591 Added 0.6%
99,620 $13.5 Million
Q3 2021

Nov 12, 2021
BUY
$106.4 - $120.78 $557,642 - $633,007
5,241 Added 5.59%
99,029 $10.7 Million
Q2 2021

Aug 16, 2021
BUY
$105.21 - $117.21 $8.76 Million - $9.75 Million
83,224 Added 787.81%
93,788 $10.6 Million
Q2 2021

Aug 16, 2021
SELL
$105.21 - $117.21 $9.58 Million - $10.7 Million
-91,094 Reduced 89.61%
10,564 $10.6 Million
Q1 2021

May 12, 2021
BUY
$102.3 - $112.62 $153,450 - $168,930
1,500 Added 1.5%
101,658 $11 Million
Q4 2020

Feb 05, 2021
BUY
$80.49 - $108.67 $656,154 - $885,877
8,152 Added 8.86%
100,158 $10.7 Million
Q3 2020

Nov 10, 2020
BUY
$85.91 - $100.83 $446,302 - $523,811
5,195 Added 5.98%
92,006 $8.06 Million
Q2 2020

Aug 13, 2020
BUY
$73.37 - $98.18 $303,238 - $405,777
4,133 Added 5.0%
86,811 $8.52 Million
Q1 2020

May 11, 2020
SELL
$64.5 - $97.79 $61,339 - $92,998
-951 Reduced 1.14%
82,678 $6.3 Million
Q4 2019

Feb 10, 2020
SELL
$72.13 - $90.25 $106,031 - $132,667
-1,470 Reduced 1.73%
83,629 $7.41 Million
Q3 2019

Nov 04, 2019
SELL
$62.98 - $75.72 $11,903 - $14,311
-189 Reduced 0.22%
85,099 $6.44 Million
Q2 2019

Aug 13, 2019
SELL
$65.7 - $83.98 $117,931 - $150,744
-1,795 Reduced 2.06%
85,288 $6.2 Million
Q1 2019

May 09, 2019
SELL
$77.14 - $90.79 $280,481 - $330,112
-3,636 Reduced 4.01%
87,083 $7.02 Million
Q4 2018

Feb 12, 2019
BUY
$77.85 - $96.01 $50,913 - $62,790
654 Added 0.73%
90,719 $8.36 Million
Q3 2018

Nov 08, 2018
BUY
$88.91 - $98.84 $34,852 - $38,745
392 Added 0.44%
90,065 $8.52 Million
Q2 2018

Aug 10, 2018
SELL
$89.78 - $106.23 $79,365 - $93,907
-884 Reduced 0.98%
89,673 $8.31 Million
Q1 2018

May 09, 2018
SELL
$92.01 - $123.21 $131,482 - $176,067
-1,429 Reduced 1.55%
90,557 $8.57 Million
Q4 2017

Feb 13, 2018
BUY
$89.56 - $98.21 $97,172 - $106,557
1,085 Added 1.19%
91,986 $8.9 Million
Q3 2017

Nov 09, 2017
SELL
$69.85 - $89.22 $37,998 - $48,535
-544 Reduced 0.59%
90,901 $8.08 Million
Q2 2017

Aug 14, 2017
BUY
N/A
91,445
91,445 $6.63 Million

Others Institutions Holding ABBV

# of Institutions
3,652
Shares Held
1.24B
Call Options Held
15.5M
Put Options Held
11.6M
View Full List

About AbbVie Inc.

ABBV Quotes by TradingView
  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $293B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Haverford Trust CO Portfolio

Follow Haverford Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Haverford Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Haverford Trust CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email